Registration Dossier
Registration Dossier
Data platform availability banner - registered substances factsheets
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 206-114-9 | CAS number: 302-01-2
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data
Basic toxicokinetics
Administrative data
- Endpoint:
- basic toxicokinetics in vivo
- Type of information:
- experimental study
- Adequacy of study:
- other information
- Reliability:
- 2 (reliable with restrictions)
- Rationale for reliability incl. deficiencies:
- other: report in brief of different application routes
Data source
Reference
- Reference Type:
- study report
- Title:
- Unnamed
- Year:
- 1 986
- Report date:
- 1986
Materials and methods
- Objective of study:
- toxicokinetics
- Principles of method if other than guideline:
- Administration of test substance via gavage, drinking water, oral undefined, subcutan, intratracheal and dermal without and with collar and availabiltiy in blood and excretion rate were determined.
- GLP compliance:
- not specified
Test material
- Reference substance name:
- hydrazine hydrate
- Cas Number:
- 10217-52-4
- Molecular formula:
- H4N2*xH2O
- IUPAC Name:
- hydrazine hydrate
- Reference substance name:
- hydrazine hydrate
- IUPAC Name:
- hydrazine hydrate
- Details on test material:
- hydrazine hydrate (99 %)
Constituent 1
Constituent 2
- Radiolabelling:
- no
Test animals
- Species:
- rat
- Strain:
- other: CPB-SPF
- Sex:
- male
- Details on test animals or test system and environmental conditions:
- TEST ANIMALS
- Weight at study initiation: 180-220 g
- metabolism cages: yes, only animals that were nominated for urinalysis
Administration / exposure
- Route of administration:
- other: (1) oral gavage, (2) drinking water, (3) oral undefined, (4) subcutan, (5) intratracheal, (6) dermal
- Vehicle:
- water
- Details on exposure:
- see section additional information on material and methods
- Duration and frequency of treatment / exposure:
- see section additional information on material and method
Doses / concentrations
- Remarks:
- Doses / Concentrations:
see section additional information on material and method
- No. of animals per sex per dose / concentration:
- see section additional information on material and method
- Control animals:
- yes
- Positive control reference chemical:
- no
- Details on study design:
- determination of hydrazine in blood:
Reaction of hydrazine with p-dimethylaminobenzaldehyd result in
Dimethylaminobenzalazin (DMABA) which is yellow and
can be extracted with chloroform and measured fluorimetrically
urinary analysis
by HPLC combined with UV-detection - Details on dosing and sampling:
- see secton addional information on material and methods
- Statistics:
- no data
Results and discussion
- Preliminary studies:
- no data
Toxicokinetic / pharmacokinetic studies
- Details on absorption:
- see section remarks on result
- Details on distribution in tissues:
- no data
Transfer into organs
- Transfer type:
- other: not determened
- Observation:
- other: no data
- Details on excretion:
- see section remarks on result
Toxicokinetic parameters
- Toxicokinetic parameters:
- other: see section remarks on results
Metabolite characterisation studies
- Metabolites identified:
- no
- Details on metabolites:
- no data
Any other information on results incl. tables
Trial (1) blood examination: rapid absorption from the gastrointestinal tract; highest concentration 15 min post application: 234 ng/ml and 441 ng/ml, respectively half live in blood: 35 min and 90 min., respectively urinalysis within 24 hours 13.1 and 16.9 % of the dose as unchanged hydrazine trial(2) blood examination 10 ppm: 13.6 ng/ml 50 ppm: 48 ng/ml urinalysis 10 ppm: 216 µmol 50 ppm: 715 µmol trial(3)-(6) (3) oral unspecified: 23.4-27.5 % of the dose (4) subcutan: 37.2-50.9 % of the dose (5) intratracheal: 28.3 % of the dose (6a) dermal (without collar) 21.1 % of the dose (6b) dermal (with collar) 14.7-7.5 % of the dose.
Applicant's summary and conclusion
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.